Evidence map›Paper›PMID 27165289›Full record

ArticleMolecular neurobiology2017

Inhibition of miR-203 Reduces Spontaneous Recurrent Seizures in Mice.

Soon-Tae Lee, Daejong Jeon, Kon Chu, Keun-Hwa Jung, Jangsup Moon, Junsang Sunwoo, Dong-Kyu Park, Hyunwoo Yang, Ji-Hyun Park, Manho Kim and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Aberrant expression of miRNAs in epilepsy.Molecular biology reports · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Antagonizing IncreasedThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Soon-Tae LeeDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Daejong JeonDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Kon ChuDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea. stemcell.snu@gmail.com.
Keun-Hwa JungDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Jangsup MoonDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Junsang SunwooDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Dong-Kyu ParkDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Hyunwoo YangDepartment of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
Ji-Hyun ParkDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Manho KimDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Jae-Kyu RohDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea.
Sang Kun LeeDepartment of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea. sangkun2923@gmail.com.
Seoul National University Hospital · KRKorea Advanced Institute of Science and Technology · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibitory synaptic receptors are dysfunctional in epileptic brains, and agents that selectively target these receptors may be effective for the treatment of epilepsy. MicroRNAs interfere with the translation of target genes, including various synaptic proteins. Here, we show that miR-203 regulates glycine receptor-β (Glrb) in epilepsy models. miR-203 is upregulated in the hippocampus of epileptic mice and human epileptic brains and is predicted to target inhibitory synaptic receptors, including Glrb. In vitro transfection, target gene luciferase assays, and analysis of human samples confirmed the direct inhibition of GLRB by miR-203, and AM203, an antagomir targeting miR-203, reversed the effect of miR-203. When intranasal AM203 was administered, AM203 reached the brain and restored hippocampal GLRB levels in epileptic mice. Finally, intranasal AM203 reduced the epileptic seizure frequency of mice. Overall, this study suggests that GLRB expression in the epileptic brain is controlled by miR-203, and intranasal delivery of AM203 showed therapeutic effects in chronic epilepsy mice.

Indexed as

AnimalsChronic DiseaseEpilepsyMaleMice, Inbred C57BLMicroRNAsProtein SubunitsReceptors, GlycineRecurrenceSeizuresUp-RegulationMicroRNAsMIRN203 microRNA, mouseProtein SubunitsReceptors, GlycineAntagomirEpilepsyGlycine receptor-betamicroRNASpontaneous recurrent seizure

Identifiers

PMID27165289
OpenAlexW2348952042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.